FOR IMMEDIATE RELEASE
BOZEMAN, MT June 18, 2025 — Montana Molecular, a biopharma company with a history of innovation in designing novel fluorescent biosensors and gene delivery tools for drug discovery and cell biology research, is pleased to announce that Dr Christopher M. Johnson, Ph.D. has joined the company as Senior Director of Operations. Dr Johnson brings a blend of scientific expertise and operational leadership, joining the company at a pivotal time as it scales its infrastructure and strategic initiatives.
Chris is a seasoned manager and expert molecular/cellular biologist with a focus on high throughput genetic screening. He previously held leadership roles at Recursion Pharmaceuticals, where he was instrumental in navigating rapid organizational growth and driving process innovation. His ability to align technical teams with business goals is an essential factor as Montana Molecular continues its trajectory of expansion.
“While rapid and sustained growth is certainly exciting, we anticipate new challenges as we adapt to changes in our processes” said Anne Marie Quinn, CEO. “Chris’s operational insight and leadership style are perfectly aligned with the collaborative and driven environment we’ve built at Montana Molecular.”
In his new position, Chris will lead company-wide operational strategy and work closely with cross-functional teams to enhance performance, scalability, and internal cohesion.
“I’m thrilled to join a company known not only for its scientific innovation but also for its strong culture of collaboration,” said Johnson. “I look forward to contributing to Montana Molecular’s continued success and supporting its evolution into the next phase of growth.”
Montana Molecular’s preclinical discovery platform enables selection of drug candidates that are most likely to succeed in the clinic by capturing pharmacological, temporal and biological signals in living cells that are relevant to disease.
For media inquiries, please contact:
info@montanamolecular.com
(406) 200-8321